covid vaccine development is going on according to plans. Aurobindo Pharma Limited is developing a vaccine for SARS COV-2 (COVID-19) through its wholly owned US subsidiary Auro Vaccines.
The SARS COV-2 vaccine candidate is based on the company’s proprietary replication-competent, attenuated, recombinant vesicular stomatitis (VSV, VesiculoVax) vaccine delivery platform.Central Drugs Standard Control Organisation (CDSCO) has granted Aurobindo Pharma test license permission for manufacture of COVID-19 vaccine for preclinical test, examination and analysis.
The government said that more than 30 vaccines against covid are in various phases of development."Aurobindo is in the process of setting up a manufacturing facility for viral vaccines which.